洛杉矶县在猴痘疫情高峰期间成功分发替考韦瑞马特(Tecovirimat):2022年6月至2023年1月
在2022-2023年猴痘疫情期间,洛杉矶县利用现有医疗对策分发网络,建立由44个枢纽设施和456个卫星站点组成的辐射式分发网络,向2281例猴痘患者中的735例(32%)提供替考韦瑞马特治疗,其中约三分之二(508例,69%)通过社区诊所和药房获得治疗,从标本采集到治疗的中位间隔为2天(IQR=0-5天)。
要点
- 洛杉矶县建立44个枢纽设施和456个卫星站点的辐射式网络分发替考韦瑞马特。
- 2281例猴痘患者中735例(32%)接受了替考韦瑞马特治疗。
- 治疗患者中约三分之二(508例,69%)通过社区诊所和药房获得治疗。
核心结论
- 在突发公共卫生事件期间,利用现有分发网络(包括诊所和药房)可在大型辖区快速部署医疗对策。
- 本地数据收集和分析有助于最大限度减少治疗获取缺口,并促进网络性能监测。
研究设计与样本
- 对洛杉矶县2022年6月至2023年1月期间猴痘患者的替考韦瑞马特治疗数据进行分析,将治疗数据与病例监测数据匹配。
- 利用公共卫生应急准备项目和医院准备项目建立的现有医疗对策分发网络,创建由44个枢纽设施服务456个卫星站点的辐射式分发网络。
主要发现
- 洛杉矶县2281例猴痘患者中,735例(32%)在2022年6月至2023年1月期间接受了替考韦瑞马特治疗。
- 接受治疗的患者中,约三分之二(508例,69%)通过社区诊所和药房获得治疗。
- 从标本采集到治疗的中位间隔为2天(IQR=0-5天)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tecovirimat is the first-line antiviral treatment recommended for severe mpox or for persons with mpox who are at risk for severe disease; tecovirimat is available in the United States under an expanded access investigational new drug (IND) protocol. During the 2022-2023 mpox outbreak, local U.S. health jurisdictions facilitated access to tecovirimat. In June 2022, Los Angeles County (LAC) rapidly developed strategies for tecovirimat distribution using existing medical countermeasure distribution networks established by the Public Health Emergency Preparedness Program and the Hospital Preparedness Program, creating a hub and spoke distribution network consisting of 44 hub facilities serving 456 satellite sites across LAC. IND patient intake forms were analyzed to describe mpox patients treated with tecovirimat. Tecovirimat treatment data were matched with case surveillance data to calculate time from specimen collection to patients receiving tecovirimat. Among 2,281 patients with mpox in LAC, 735 (32%) received tecovirimat during June 2022-January 2023. Among treated patients, approximately two thirds (508; 69%) received treatment through community clinics and pharmacies. The median interval from specimen collection to treatment was 2 days (IQR = 0-5 days). Local data collection and analysis helped to minimize gaps in treatment access and facilitated network performance monitoring. During public health emergencies, medical countermeasures can be rapidly deployed across a large jurisdiction using existing distribution networks, including clinics and pharmacies.
引用
- O'Neil MJ, Archer R, Danza P, et al. Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38900699. doi:10.15585/mmwr.mm7324a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。